m.wanjala
TL1 Member · Kuopio, FI
Joined after a search result brought me to one of the reconstitution pages. Stayed for the tone.
Joined 21 June 2025 · last posted 1d
30 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #115 · Analytics › COA interpretation · 27 Jul 2026 · 20 likes Worth separating two things that post #111 runs together. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase…
-
Here for the analytics and not much else Replied, post #85 · Lounge › Introductions · 24 Jul 2026 · 13 likes On post #81 — agreed on the reasoning, with one qualification. Community culture: introductions give you a sense of who is here. Reading a few introduces you to the…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #50 · Sourcing › Regulatory · 21 Jul 2026 · 15 likes Picking up post #47: that is the part I would want checked first. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #102 · Evidence › Preprints · 10 Jul 2026 · 19 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #26 · Nutrition & Training › Protein & intake · 2 Jul 2026 · 19 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #127 · Access › Insurance & coverage · 20 Jun 2026 · 6 likes Picking up post #124: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #33 · Compounds › Oral incretins · 8 Jun 2026 · 1 like post #32 is right about the mechanism and I think understates the practical bit. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type…
-
Injection volume, overload, and peak distortion Replied, post #35 · Analytics › HPLC & UHPLC · 4 Jun 2026 · 2 likes On post #31 — agreed on the reasoning, with one qualification. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
-
Revisiting: The best-written scientific paper you have read Replied, post #6 · Lounge › Off topic · 28 May 2026 · 3 likes Worth separating two things that post #2 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Review: an evidence digest and the citation check that delayed it Replied, post #6 · Documentation › Doc review · 12 May 2026 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here.…
-
Request: show the solution author in the topic list — what changed since Replied, post #76 · Meta › Feature requests · 4 May 2026 · 15 likes Worth separating two things that post #72 runs together. Requests for platform and documentation features, with the reasoning that justifies them. If you think the site…
-
Prediction intervals and why they are more honest than confidence intervals Replied, post #6 · Evidence › Meta-analyses · 2 Apr 2026 · 5 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #87 · Analytics › Mass spectrometry · 29 Mar 2026 · 2 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
-
Designing a personal experiment that could change your mind — one year on Replied, post #12 · Research Methods › N-of-1 designs · 17 Feb 2026 · 8 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #67 · Practice › Storage & stability · 16 Feb 2026 · 18 likes Worth separating two things that post #63 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #47 · Practice › Dosing & titration · 24 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A partial dose because the pen emptied mid-injection Replied, post #59 · Practice › Administration · 9 Jan 2026 · 0 likes post #58 is right about the mechanism and I think understates the practical bit. Cold solution and stinging: warming the vial in your hands for a minute before…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #19 · Clinical › Bloodwork · 6 Jan 2026 · 1 like post #18 is right about the mechanism and I think understates the practical bit. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things.…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #36 · Sourcing › Independent verification · 8 Dec 2025 · 2 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
[2026 update] What steady state means for the decision to escalate Replied, post #105 · Practice › Dosing & titration · 16 Nov 2025 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
A 40-week log with the measurement method stated Replied, post #73 · Outcomes › Progress reports · 26 Oct 2025 · 0 likes Worth separating two things that post #69 runs together. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool;…
-
Journal club: PIONEER 6 as a safety trial Replied, post #4 · Evidence › Journal club · 21 Sep 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Washout: how long is long enough, and for what purpose Replied, post #51 · Pharmacology › Pharmacokinetics · 1 Aug 2025 · 0 likes Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the oral dose (14 mg) is so much larger than the…
-
About the Tirzepatide category Replied, post #7 · Compounds › Tirzepatide · 26 Jun 2025 · 5 likes This follows post #4 rather than contradicting it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The…
-
Reading a trial's population section before its results — does this still hold? Replied, post #52 · Evidence › Trials · 29 Apr 2025 · 15 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #109 · Compounds › Semaglutide · 17 Feb 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #20 · Compounds › Tirzepatide · 12 Feb 2025 · 3 likes I read post #18 twice before replying, because I had assumed the opposite. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that…
-
Converting between mg/mL and units per dose, both directions Replied, post #83 · Practice › Reconstitution · 10 Nov 2024 · 1 like This follows post #80 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #8 · Clinical › Special populations · 3 Nov 2024 · 26 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #29 · Analytics › Mass spectrometry · 16 Aug 2024 · 18 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…